Oxford Nanopore seeks legal action against BGI over contract breach allegations.
- The UK firm filed in a US court supporting potential litigation in England and Wales.
- Claims include breaches of contract, confidentiality, and misappropriation of trade secrets.
- BGI, a former customer, allegedly used Oxford’s tech to develop its own platform.
- Oxford Nanopore’s share prices have experienced a slight decline following the news.
Oxford Nanopore has announced intentions to initiate legal proceedings against the Chinese biotechnology company BGI, citing alleged breaches of contract. This includes accusations of violating both common law obligations of confidence and specific trade secret regulations. The British firm is actively pursuing the necessary legal channels, having submitted an application in a United States court to serve subpoenas, thereby facilitating a potential lawsuit in the courts of England and Wales.
Oxford Nanopore, a forerunner in molecular sensing technology, has asserted that BGI, previously one of its clients, may have leveraged its proprietary technology for commercial objectives without consent. This, according to Oxford Nanopore, has culminated in the unauthorised development of a nanopore-based sequencing platform by BGI, constituting a breach of the initial contractual agreement between the two entities.
The lawsuit claims encompass breaches related to contractual obligations, as well as infringement of trade secrets under the Trade Secrets (Enforcement etc.) Regulations 2018. Additionally, Oxford Nanopore is pursuing claims related to the potential entitlement to certain patent licences, which they allege BGI has utilised without proper authorisation.
Oxford Nanopore has expressed its belief that BGI’s technology could potentially infringe upon its broad portfolio of proprietary rights, raising concerns about unauthorised use in BGI’s commercial products. The company’s spokesperson, however, refrained from providing detailed comments regarding ongoing litigation activities.
Following these revelations, Oxford Nanopore experienced a 2.8% decline in its share price, underscoring the financial market’s response to legal disputes of this nature. The company remains firm in its position, highlighting its commitment to protecting its intellectual property against perceived breaches.
Oxford Nanopore is steadfast in its legal pursuit to safeguard its technological innovations and intellectual property.
